A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of the Zolpidem Tartrate Sublingual Lozenge in Adult Subjects With Insomnia Characterized by Difficulty Returning to Sleep After Awakening in the Middle-of-the-Night (MOTN).

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of the Zolpidem Tartrate Sublingual Lozenge in Adult Subjects With Insomnia Characterized by Difficulty Returning to Sleep After Awakening in the Middle-of-the-Night (MOTN).

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Sleep maintenance insomnia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 19 Nov 2010 Results presented at the 10th International Forum on Mood and Anxiety Disorders.
    • 16 Jun 2009 Actual initiation date (May 2007), actual end date (Nov 2007) and actual number of patients (295) added as reported by ClinicalTrials.gov.
    • 09 Jun 2009 Results presented at the 23rd Annual Meeting of the Associated Professional Sleep Societies in Seattle, Washington USA, accoridng to Transcept Pharmeuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top